The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
31 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $17,541,701 in first-year total cost, median $622,537.
Most frequent study sections
- Special Emphasis Panel[ZRG1 EMNR-S (55)]16
- Special Emphasis Panel[ZRG1 MCST-M (81)]9
- Special Emphasis Panel[ZRG1 EMNR-D (56)]2
- Special Emphasis Panel[ZRG1 EMS-S (55)]1
- Special Emphasis Panel[ZRG1-EMNR-D(56)R]1
Most frequent institutions
- BRIGHAM AND WOMEN'S HOSPITAL3
- JOHNS HOPKINS UNIVERSITY3
- DUKE UNIVERSITY2
- TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR2
- UNIVERSITY OF CALIFORNIA LOS ANGELES2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Multimodal brain imaging of the neural effects of methylphenidate in patients with ADHD1R01MH133453-01A1 | BIGOS, KRISTIN L | JOHNS HOPKINS UNIVERSITY, MD | $700,166 | ZRG1 |
| 2024 | Drug repurposing of a novel synthetic progestin for the prevention of preterm labor and fetal inflammation1R01HD114495-01 | KALLAPUR, SUHASMESIANO, SAM ANTONIO | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $696,840 | ZRG1 |
| 2024 | Reversing disrupted developmental sterol biosynthesis by prescription medications1R56HD111119-01A1 | KORADE, ZELJKAMIRNICS, KAROLY | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $230,250 | ZRG1 |
| 2023 | PRISM1R01HD113201-01 | GONZALEZ, DANIELLANG, JASON E.LAUGHON, MATTHEW | DUKE UNIVERSITY, NC | $764,847 | ZRG1 |
| 2023 | Optimal Oxygenation in Neonatal Lung Injury2R01HD072929-12A1 | LAKSHMINRUSIMHA, SATYANARAYANA | UNIVERSITY OF CALIFORNIA AT DAVIS, CA | $687,830 | ZRG1 |
| 2023 | Efficacy and safety of nanoparticle mediated placental gene therapy in nonhuman primates1R01HD113327-01 | JONES, HELEN NSCHMIDT, JENNA ANN | UNIVERSITY OF FLORIDA, FL | $676,429 | ZRG1 |
| 2023 | Developmental effects of antenatal exposure to antipsychotics1R01HD111117-01 | ROBAKIS, THALIA K | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $635,113 | ZRG1 |
| 2023 | Detecting pathogen and host factors on extracellular vesicles for pediatric TB diagnosis and management2R01HD090927-07 | HU, TONY Y.LYON, CHRISTOPHER JMITCHELL, CHARLES DEBEAUX | TULANE UNIVERSITY OF LOUISIANA, LA | $632,390 | ZRG1 |
| 2023 | Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity1R01HD111125-01A1 | ERICKSON, ELISE N | UNIVERSITY OF ARIZONA, AZ | $612,087 | ZRG1 |
| 2023 | Ketamine to reduce postpartum depression and pain after cesarean delivery1R01MH134538-01 | LIM, GRACE | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $596,511 | ZRG1 |
| 2023 | Dose Flexible Combination 3D-Printed Delivery Systems for Antiviral Therapy in Children1R01HD112077-01 | KHAN, MANSOOR ARAHMAN, ZIYAUR | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $543,681 | ZRG1 |
| 2023 | Uncovering Microbial Modifiers of Antidepressant Responses during Pregnancy1R01HD111079-01 | HSIAO, ELAINE | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $501,675 | ZRG1 |
| 2023 | Investigating the molecular mechanism of P-gp/NHERF-1 network at feto maternal interface and role of paracrine signaling of EVs containing drug transporter proteins1R01HD113193-01 | KAMMALA, ANANTH KUMAR | UNIVERSITY OF TEXAS MED BR GALVESTON, TX | $356,400 | ZRG1 |
| 2023 | Targeting the Thromboinflammatory Response to Mitigate Bowel Injury in Necrotizing Enterocolitis1R56HD112046-01 | DIACOVO, THOMAS G | STATE UNIVERSITY NEW YORK STONY BROOK, NY | $239,250 | ZRG1 |
| 2022 | Precision Dosing for Critically Ill Children1R01HD107687-01 | NEELY, MICHAEL N. | CHILDREN'S HOSPITAL OF LOS ANGELES, CA | $725,833 | ZRG1 |
| 2022 | Advanced therapeutic hypothermia efficacy network modeling in neonatal HIE1R01HD110091-01 | EVERETT, ALLEN DNORTHINGTON, FRANCES J | JOHNS HOPKINS UNIVERSITY, MD | $715,813 | ZRG1 |
| 2022 | Big data apprOaches fOr Safe Therapeutics in Healthy Pregnancies (BOOST-HP)1R01HD110107-01 | MARO, JUDITHWINTERSTEIN, ALMUT G | HARVARD PILGRIM HEALTH CARE, INC., MA | $706,955 | ZRG1 |
| 2022 | Off-label drugs in cardiology: evaluating age- and disease-appropriate therapies1R01HD108839-01 | POSNACK, NIKKI GILLUM | CHILDREN'S RESEARCH INSTITUTE, DC | $685,049 | ZRG1 |
| 2022 | Phase 1 Study of In Utero Enzyme Replacement Therapy for the Treatment of Lysosomal Storage Diseases1R01HD110270-01 | MACKENZIE, TIPPI | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $681,906 | ZRG1 |
| 2022 | Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease1R01HD106588-01A1 | HORNIK, CHRISTOPH | DUKE UNIVERSITY, NC | $649,188 | ZRG1 |
| 2022 | Comparative Safety of Antibiotics for Common Bacterial Infections During Pregnancy1R01HD107759-01 | ZHU, YANMIN | BRIGHAM AND WOMEN'S HOSPITAL, MA | $645,688 | ZRG1 |
| 2022 | TreeScan to Evaluate the Safety of New Drugs in Pediatric Populations1R01HD110092-01 | HUYBRECHTS, KRISTA FWANG, SHIRLEY | BRIGHAM AND WOMEN'S HOSPITAL, MA | $626,758 | ZRG1 |
| 2022 | Safety of Combinatorial Therapy with Erythropoietin and Melatonin for Preterm Infants with Intraventricular Hemorrhage1R01HD104673-01A1 | ROBINSON, SHENANDOAH | JOHNS HOPKINS UNIVERSITY, MD | $622,537 | ZRG1 |
| 2022 | Maternal COVID-19 Vaccination and Lactation Outcomes1R01HD107753-01 | PALMSTEN, KRISTIN | HEALTHPARTNERS INSTITUTE, MN | $618,968 | ZRG1 |
| 2022 | Mechanisms and blood-based biomarkers of intergenerational neurobehavioral effects of general anesthetics1R01HD107722-01A1 | MARTYNYUK, ANATOLY E | UNIVERSITY OF FLORIDA, FL | $477,998 | ZRG1 |
| 2022 | Pulmonary implications of perinatal acetaminophen exposure1R01HD107700-01 | WRIGHT, CLYDE JASON | UNIVERSITY OF COLORADO DENVER, CO | $408,563 | ZRG1 |
| 2022 | Mind the gaps: Pharmacokinetic research to advance pediatric HIV/TB cotreatment and TB prevention1R01HD107726-01 | RAWIZZA, HOLLY ELIZABETH | BRIGHAM AND WOMEN'S HOSPITAL, MA | $322,814 | ZRG1 |
| 2022 | Precision Alemtuzumab Therapy in Allogeneic HCT1R01HD107690-01A1 | MARSH, REBECCA | CINCINNATI CHILDRENS HOSP MED CTR, OH | $297,995 | ZRG1 |
| 2021 | A Safer Glucocorticoid to Treat Neonatal Lung Injury with Limited Adverse Neurologic Effects1R01HD104215-01A1 | DEFRANCO, DONALD BMONAGHAN-NICHOLS, A PAULASAMPATH, VENKATESH | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | $606,797 | ZRG1 |
| 2021 | Small Molecule Drug Discovery for CLN3 and CLN6 Disease1R01HD106590-01 | TRIPPIER, PAUL | UNIVERSITY OF NEBRASKA MEDICAL CENTER, NE | $540,353 | ZRG1 |
| 2021 | Age-appropriate flexible pediatric drug delivery systems1R56HD106612-01 | KHAN, MANSOOR A | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR, TX | $335,017 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.